Legacy RTSM Sacrificed Reusability For Speed
The assumption that Interactive Response Technology (IRT) operates on a "set it and forget it" standard is one of the most persistent myths in clinical trial management. Many clinical operations teams approach UAT with the expectation that once a workflow is validated, it remains a permanent blueprint for future studies. However, the reality is often far more fragmented. When systems that look identical on the surface perform differently in practice, UAT cycles stretch longer, and execution slows down. By diving into the architectural differences between truly configurable systems and those built on study-specific "customizations," you can better identify why your software might be working against your timelines. Understanding these hidden technical nuances is the first step toward reclaiming predictability in your clinical supply chain and ensuring your technology finally behaves the way your team expects it to.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.